Cargando…
Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report
BACKGROUND: Primary carcinosarcoma of the bladder is a rare and highly aggressive tumor, representing less than 1% of all bladder neoplasms. There is no specific treatment guideline has for carcinosarcoma of the bladder, and majority of published patients was treated exclusively by surgery. CASE PRE...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354986/ https://www.ncbi.nlm.nih.gov/pubmed/37464254 http://dx.doi.org/10.1186/s13256-023-04028-3 |
_version_ | 1785075042502049792 |
---|---|
author | Kouhen, Fadila Dahbi, Zineb Afif, Mohammed Chihabeddine, Meriem Errafiy, Nadia Oqbani, Kenza Omor, Youssef Elhossini, Amal |
author_facet | Kouhen, Fadila Dahbi, Zineb Afif, Mohammed Chihabeddine, Meriem Errafiy, Nadia Oqbani, Kenza Omor, Youssef Elhossini, Amal |
author_sort | Kouhen, Fadila |
collection | PubMed |
description | BACKGROUND: Primary carcinosarcoma of the bladder is a rare and highly aggressive tumor, representing less than 1% of all bladder neoplasms. There is no specific treatment guideline has for carcinosarcoma of the bladder, and majority of published patients was treated exclusively by surgery. CASE PRESENTATION: We report a case of 65-year-old Moroccan man, presented with macroscopic hematuria, pollakiuria and painful urination. Histological analysis showed a biphasic epithelial and mesenchymal proliferation, with invasion of lamina propria and muscularis, compatible with diagnosis of bladder carcinosarcoma. The patient was treated with cystectomy and adjuvant chemotherapy based on gemcitabin-cisplatin, 18 months after treatment, patient still free of recurrence. CONCLUSION: Carcinosarcoma of the urinary bladder is a rare and aggressive tumor regardless treatment. A multidisciplinary management based on radical cystectomy and combined adjuvant treatments can improve prognosis. In this work, we suggest to propose adjuvant chemotherapy whenever possible. |
format | Online Article Text |
id | pubmed-10354986 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-103549862023-07-20 Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report Kouhen, Fadila Dahbi, Zineb Afif, Mohammed Chihabeddine, Meriem Errafiy, Nadia Oqbani, Kenza Omor, Youssef Elhossini, Amal J Med Case Rep Case Report BACKGROUND: Primary carcinosarcoma of the bladder is a rare and highly aggressive tumor, representing less than 1% of all bladder neoplasms. There is no specific treatment guideline has for carcinosarcoma of the bladder, and majority of published patients was treated exclusively by surgery. CASE PRESENTATION: We report a case of 65-year-old Moroccan man, presented with macroscopic hematuria, pollakiuria and painful urination. Histological analysis showed a biphasic epithelial and mesenchymal proliferation, with invasion of lamina propria and muscularis, compatible with diagnosis of bladder carcinosarcoma. The patient was treated with cystectomy and adjuvant chemotherapy based on gemcitabin-cisplatin, 18 months after treatment, patient still free of recurrence. CONCLUSION: Carcinosarcoma of the urinary bladder is a rare and aggressive tumor regardless treatment. A multidisciplinary management based on radical cystectomy and combined adjuvant treatments can improve prognosis. In this work, we suggest to propose adjuvant chemotherapy whenever possible. BioMed Central 2023-07-19 /pmc/articles/PMC10354986/ /pubmed/37464254 http://dx.doi.org/10.1186/s13256-023-04028-3 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Kouhen, Fadila Dahbi, Zineb Afif, Mohammed Chihabeddine, Meriem Errafiy, Nadia Oqbani, Kenza Omor, Youssef Elhossini, Amal Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report |
title | Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report |
title_full | Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report |
title_fullStr | Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report |
title_full_unstemmed | Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report |
title_short | Bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report |
title_sort | bladder carcinosarcoma treated by cystectomy and adjuvant chemotherapy with good outcomes: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354986/ https://www.ncbi.nlm.nih.gov/pubmed/37464254 http://dx.doi.org/10.1186/s13256-023-04028-3 |
work_keys_str_mv | AT kouhenfadila bladdercarcinosarcomatreatedbycystectomyandadjuvantchemotherapywithgoodoutcomesacasereport AT dahbizineb bladdercarcinosarcomatreatedbycystectomyandadjuvantchemotherapywithgoodoutcomesacasereport AT afifmohammed bladdercarcinosarcomatreatedbycystectomyandadjuvantchemotherapywithgoodoutcomesacasereport AT chihabeddinemeriem bladdercarcinosarcomatreatedbycystectomyandadjuvantchemotherapywithgoodoutcomesacasereport AT errafiynadia bladdercarcinosarcomatreatedbycystectomyandadjuvantchemotherapywithgoodoutcomesacasereport AT oqbanikenza bladdercarcinosarcomatreatedbycystectomyandadjuvantchemotherapywithgoodoutcomesacasereport AT omoryoussef bladdercarcinosarcomatreatedbycystectomyandadjuvantchemotherapywithgoodoutcomesacasereport AT elhossiniamal bladdercarcinosarcomatreatedbycystectomyandadjuvantchemotherapywithgoodoutcomesacasereport |